To differentiate misfolded tau seeds in postmortem tauopathy brains from normal controls, an endpoint RT-QuIC-based tau-aggregation seeding activity (tau-ASA) assay was developed using tau fragment 4RCF as the substrate. Here, MAPT is linked to tauopathy.